Menora Mivtachim Holdings Ltd. Eloxx Pharmaceuticals, Inc. Transaction History

Menora Mivtachim Holdings Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 30, 2020	SELL	$3.19 - $7.56 $15,312 - $36,288	-4,800 Reduced 0.23%	2,094,208 $15.4 Million
Q3 2019 Oct 31, 2019	SELL	$4.37 - $9.91 $452,067 - $1.03 Million	-103,448 Reduced 4.7%	2,099,008 $9.49 Million
Q2 2019 Aug 01, 2019	BUY	$8.77 - $12.49 $2.81 Million - $4 Million	320,000 Added 17.0%	2,202,456 $22 Million
Q3 2018 Nov 13, 2018	BUY	$11.95 - $19.63 $2.02 Million - $3.32 Million	169,077 Added 9.87%	1,882,456 $32.1 Million
Q2 2018 Aug 01, 2018	BUY	$8.75 - $23.27 $15 Million - $39.9 Million	1,713,379 New	1,713,379 $29.2 Million

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Menora Mivtachim Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Menora Mivtachim Holdings Ltd. with notifications on news.